Francesca Zimetti
Parma, 43124, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Optimization of 4-Amino-2-Pyridone Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9: Integrating Structure-Activity and Structure-Metabolism Relationships.
Journal: ChemMedChem
Published: July 27, 2025
Mechanisms, Mediators, and Pharmacological Approaches Targeting Brain Cholesterol Transport in Alzheimer's Disease.
Journal: Current pharmaceutical design
Published: April 29, 2025
Influence of APOE4 genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum.
Journal: Journal of Alzheimer's disease : JAD
Published: November 05, 2024
Anti-atherosclerotic effects of natural compounds targeting lipid metabolism and inflammation: Focus on PPARs, LXRs, and PCSK9.
Journal: Atherosclerosis plus
Published: October 18, 2024
HDL cholesterol efflux capacity and cholesterol loading capacity in long-term fasting: Evidence from a prospective, single-arm interventional study in healthy individuals.
Journal: Atherosclerosis
Published: April 26, 2024
Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial.
Journal: International journal of molecular sciences
Published: February 16, 2024
Effect of the JAK/STAT Inhibitor Tofacitinib on Macrophage Cholesterol Metabolism.
Journal: International journal of molecular sciences
Published: July 28, 2023
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability.
Journal: European journal of medicinal chemistry
Published: June 09, 2023
Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis.
Journal: Journal of translational autoimmunity
Published: May 03, 2023
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice.
Journal: Brain, behavior, and immunity
Published: March 27, 2023
Last Updated: 09/26/2026